Final overall survival (OS) analysis of a multicenter phase II study of concurrent high-dose (72Gy) three-dimensional conformal radiotherapy (3D-RT) without elective nodal irradiation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback